Healthcare >> Analyst Interviews >> November 2, 2009

Investing In Indian Pharma – Prashant Nair – Citi Investment Research

Prashant Nair is a Mumbai-based Director and Analyst who covers the Indian pharmaceutical, health care and agrochemical sectors for Citi Investment Research. Mr. Nair joined Citigroup in July 2005 from Motilal Oswal Securities. Prior to that, he was with Edelweiss Capital and Pranav Securities. Mr. Nair obtained his MBA from the Institute of Technology & Management and a Bachelor of Commerce from the University of Mumbai. He is also a CFA charterholder and a Cost Accountant by training. Profile
TWST: Where are you focusing your attention in the smaller-cap pharma space these days? I understand you focus on Indian stocks?

Mr. Nair: Basically, I cover Indian pharmaceuticals and most of my